Sande O Okelo1, Michelle N Eakin2, Kristin A Riekert2, Alvin P Teodoro3, Andrew L Bilderback2, Darcy A Thompson4, Antonio Loiaza-Martinez5, Cynthia S Rand2, Shannon Thyne6, Gregory B Diette2, Cecilia M Patino7. 1. Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, Calif. Electronic address: sokelo@mednet.ucla.edu. 2. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Md. 3. Department of Pediatrics, New York Presbyterian/Weill Medical College of Cornell University, New York, NY. 4. Department of Pediatrics, University of Colorado, Denver, Colo. 5. Division of Pediatric Pulmonology, Hospital Infantil de Las Californias, Tijuana, Mexico. 6. Department of Pediatrics, University of California San Francisco, San Francisco, Calif. 7. Department of Preventive Medicine, University of Southern California, Los Angeles, Calif.
Abstract
BACKGROUND: Despite a growing interest, few pediatric asthma questionnaires assess multiple dimensions of asthma morbidity, as recommended by national asthma guidelines, or use patient-reported outcomes. OBJECTIVE: To evaluate a questionnaire that measures multiple dimensions of parent-reported asthma morbidity (Direction, Bother, and Risk). METHODS: We administered the Pediatric Asthma Control and Communication Instrument (PACCI) and assessed asthma control (PACCI Control), quality of life, and lung function among children who presented for routine asthma care. The PACCI was evaluated for discriminative validity. RESULTS: A total of 317 children participated (mean age, 8.2 years; 58% boys; 44% African American). As parent-reported PACCI Direction changed from "better" to "worse," we observed poorer asthma control (P < .001), mean Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ) scores (P < .001), and FEV1% (P = .025). Linear regression showed that, for each change in PACCI Direction, the mean PACQLQ score decreased by -0.6 (95% CI, -0.8 to -0.4). As parent-reported PACCI Bother changed from "not bothered" to "very bothered," we observed poorer asthma control (P < .001) and lower mean PACQLQ scores (P < .001). Linear regression showed that, for each change in PACCI Bother category, the mean PACQLQ score decreased by -1.1 (95% CI, -1.3 to -0.9). Any reported PACCI Risk event (emergency department visit, hospitalization, or use of an oral corticosteroid) was associated with poorer asthma control (P < .05) and PACQLQ scores (P < .01). CONCLUSIONS: PACCI Direction, Bother, and Risk are valid measures of parent-reported outcomes and show good discriminative validity. The PACCI is a simple clinical tool to assess multiple dimensions of parent-reported asthma morbidity, in addition to risk and control.
BACKGROUND: Despite a growing interest, few pediatric asthma questionnaires assess multiple dimensions of asthma morbidity, as recommended by national asthma guidelines, or use patient-reported outcomes. OBJECTIVE: To evaluate a questionnaire that measures multiple dimensions of parent-reported asthma morbidity (Direction, Bother, and Risk). METHODS: We administered the Pediatric Asthma Control and Communication Instrument (PACCI) and assessed asthma control (PACCI Control), quality of life, and lung function among children who presented for routine asthma care. The PACCI was evaluated for discriminative validity. RESULTS: A total of 317 children participated (mean age, 8.2 years; 58% boys; 44% African American). As parent-reported PACCI Direction changed from "better" to "worse," we observed poorer asthma control (P < .001), mean Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ) scores (P < .001), and FEV1% (P = .025). Linear regression showed that, for each change in PACCI Direction, the mean PACQLQ score decreased by -0.6 (95% CI, -0.8 to -0.4). As parent-reported PACCI Bother changed from "not bothered" to "very bothered," we observed poorer asthma control (P < .001) and lower mean PACQLQ scores (P < .001). Linear regression showed that, for each change in PACCI Bother category, the mean PACQLQ score decreased by -1.1 (95% CI, -1.3 to -0.9). Any reported PACCI Risk event (emergency department visit, hospitalization, or use of an oral corticosteroid) was associated with poorer asthma control (P < .05) and PACQLQ scores (P < .01). CONCLUSIONS: PACCI Direction, Bother, and Risk are valid measures of parent-reported outcomes and show good discriminative validity. The PACCI is a simple clinical tool to assess multiple dimensions of parent-reported asthma morbidity, in addition to risk and control.
Authors: Sande O Okelo; Michelle N Eakin; Cecilia M Patino; Alvin P Teodoro; Andrew L Bilderback; Darcy A Thompson; Antonio Loiaza-Martinez; Cynthia S Rand; Shannon Thyne; Gregory B Diette; Kristin A Riekert Journal: J Allergy Clin Immunol Date: 2013-02-21 Impact factor: 10.793
Authors: Sandra R Wilson; Cynthia S Rand; Michael D Cabana; Michael B Foggs; Jill S Halterman; Lynn Olson; William M Vollmer; Rosalind J Wright; Virginia Taggart Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Karin B Yeatts; Brian Stucky; David Thissen; Deb Irwin; James W Varni; Esi Morgan DeWitt; Jin-Shei Lai; Darren A DeWalt Journal: J Asthma Date: 2010-04 Impact factor: 2.515
Authors: Cecilia M Patino; Sande O Okelo; Cynthia S Rand; Kristin A Riekert; Jerry A Krishnan; Kathy Thompson; Ruth I Quartey; Deanna Perez-Williams; Andrew Bilderback; Barry Merriman; Laura Paulin; Nadia Hansel; Gregory B Diette Journal: J Allergy Clin Immunol Date: 2008-10-11 Impact factor: 10.793
Authors: Gregory B Diette; Cecilia M Patino; Barry Merriman; Laura Paulin; Kristin Riekert; Sande Okelo; Kathy Thompson; Jerry A Krishnan; Ruth Quartey; Deanna Perez-Williams; Cynthia Rand Journal: Arch Intern Med Date: 2007-07-09
Authors: Melissa H Bellin; Philip Osteen; Joan Kub; Mary E Bollinger; Mona Tsoukleris; Laurie Chaikind; Arlene M Butz Journal: J Pediatr Health Care Date: 2015-05-30 Impact factor: 1.812
Authors: Hala G Elnady; Lobna S Sherif; Hala D ElGindi; Fatma A Shaaban; Aida M Abdelmohsen; Dina A Salah; Ghada A Abdel-Latif; Reham F Fahmy Journal: Indian J Community Med Date: 2020-10-28